Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease

Abstract Individuals with chronic kidney disease are at an increased risk for cardiovascular disease. This risk may partially be explained by a chronic inflammatory state in these patients, reflected by increased arterial wall and cellular inflammation. Statin treatment decreases cardiovascular risk...

Full description

Saved in:
Bibliographic Details
Main Authors: Renate M. Hoogeveen, Simone L. Verweij, Yannick Kaiser, Jeffrey Kroon, Hein J. Verberne, Liffert Vogt, Sophie J. Bernelot Moens, Erik S. G. Stroes
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/5c18abc477fa4ebbbdfb11d89e5dbb97
Tags: Add Tag
No Tags, Be the first to tag this record!